Felbamate in Epilepsy Therapy
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 21 (3) , 225-239
Abstract
Felbamate demonstrates a unique therapeutic profile and often results in seizure control when other agents fail. Its use has been associated with risks for aplastic anaemia and hepatic failure. A...Keywords
This publication has 56 references indexed in Scilit:
- Pharmacokinetic Interactions with FelbamateClinical Pharmacokinetics, 1997
- Identification of Modified Atropaldehyde Mercapturic Acids in Rat and Human Urine after Felbamate AdministrationChemical Research in Toxicology, 1997
- An epidemiological study of aplastic anaemia: relationship of drug exposures to clinical features and outcomeEuropean Journal of Haematology, 1996
- Synthesis andin VitroReactivity of 3-Carbamoyl-2-phenylpropionaldehyde and 2-Phenylpropenal: Putative Reactive Metabolites of FelbamateChemical Research in Toxicology, 1996
- Experience‐Based Teaching of Therapeutics and Clinical Pharmacology of Antiepileptic Drugs. Sudden Unexplained Death in Epilepsy: Do Antiepileptic Drugs Have a Role?The Journal of Clinical Pharmacology, 1995
- Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactionsPharmacogenetics, 1994
- The Role of Leukocyte-Generated Reactive Metabolites in the Pathogenesis of Ideosyncratic Drug ReactionsDrug Metabolism Reviews, 1992
- Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.Journal of Clinical Investigation, 1988
- Drug-Induced Aplastic Anaemia and AgranulocytosisDrugs, 1986
- Predisposition to Phenytoin Hepatotoxicity Assessed in VitroNew England Journal of Medicine, 1981